Skip to main content
Bone, Skin, & Muscle Health

Bone Health: The Impact of Daily Toxicant Exposures

|
Reading Time: 6 minutes
|
Written on: July 22, 2024

Learn proven functional medicine strategies for treating toxic exposures at the upcoming Environmental Health Advanced Practice Module. See full program details


Beyond the obvious functions of protecting vital organs, providing structure and shape, and permitting movement of the body, bones also play a vital role in physiological homeostasis through their nutrient storage and blood cell production capabilities. In addition, the skeletal system is intricately connected to the health of other body systems such as the immune,1 endocrine,2,3 and digestive systems.4

Bone health is crucial for overall health, and several modifiable and nonmodifiable factors, from aging to genetics5 to nutrient insufficiencies, may disrupt the balance of the bone remodeling cycle and negatively impact optimal bone functioning. Research studies also suggest that chronic exposure to environmental toxicants damages bone health and function while also increasing risk of fracture and osteoporosis. What lifestyle-based approaches may help protect bone from the detrimental effects of daily pollutant and chemical exposures?

Heavy Metals, EDCs, and Combined Chemical Exposures

Medical experts and observational study results suggest that exposures to heavy metals such as lead and cadmium, as well as to endocrine-disrupting chemicals (EDCs) such as phthalates and bisphenols, disrupt bone metabolism and may increase risks of osteoporosis, osteopenia, or fracture among some populations.6-9

A 2023 study that used data from the National Health and Nutrition Examination Surveys (NHANES) 2013-2014 and 2017-2018 found that among 1,777 middle-aged and elderly participants (average age of 59 years; 62% white; 50% male), increased blood levels of cadmium were significantly associated with an increased osteoporosis prevalence.10 In subgroup analysis, researchers noted that the significant association was only seen in women. Of interesting note, results indicated that selenium may play a protective role, as osteoporosis prevalence decreased as blood levels of selenium increased.10 A 2022 meta-analysis of ten cross-sectional studies found that among postmenopausal women, even low levels of cadmium exposure may be a risk factor for osteoporosis.11 Further, a recent 2023 observational study investigated the health inequities associated with cadmium exposure and bone mineral density (BMD) among US adults and found that negative associations between cadmium exposures and lumbar BMD were most pronounced among Black women.12

Regarding recent EDC studies, a 2020 observational study used data from NHANES from 2005 to 2010 (n=2,267 men and 2,178 women, of which 1,033 were postmenopausal) to measure associations between phenolic biomarkers and BMD.9 Among the results, researchers reported that higher urinary levels of bisphenol A (BPA) were associated with a higher prevalence of both osteopenia and osteoporosis in the lumbar spine among women who were postmenopausal.9 Most recently, a 2023 in vitro study using human osteoblasts found that after treatment with some BPA analogs, cell proliferation was inhibited in a dose-dependent manner, apoptosis increased at high doses, and reductions in calcium nodule formation on osteoblasts were observed.13

In the modern world, daily exposure to a variety of ubiquitous chemicals is difficult to avoid entirely. Research studies have recently investigated the impact of cumulative exposure to multiple hazardous chemicals in relation to bone health. A 2023 study that used data from NHANES 2005 to 2010, 2013, and 2014 (n=6,766 adults; average age 52.9 years) explored the association between urinary levels of phenols, pesticides, phthalates, and polycyclic aromatic hydrocarbon metabolites with BMD measurements and osteoporosis risk.14 Overall analysis indicated that as chemical exposure levels increased, a significantly reduced BMD was reported for both men and women, while a significantly elevated osteoporosis risk was reported among women only.14

Air Pollution & Osteoporosis Genetic Predisposition

Ambient air pollutants such as particulate matter (PM), nitrogen dioxide (NO2), and nitrogen oxide (NOx) continue to be associated with reduced BMD and increases in osteoporosis and fracture risk.15,16 Some studies have also explored how genetic predisposition for fracture or osteoporosis may modify the associations between air pollution exposure and bone health.17 A 2023 observational study analyzed data from the UK Biobank to evaluate the relationship between osteoporosis risk, air pollutants, and genetics.18 Overall, statistically significant results indicated that as exposures to PM2.5, NO2, NOx, and cumulative air pollutants increased, risk of osteoporosis and fracture also increased.18 Specifically, researchers reported that compared to the lowest air pollution scores, participants with the highest air pollution scores had a 14% increased risk for osteoporosis and an 8% increased risk for fracture.18 When considering the osteoporosis genetic predisposition, researchers found the interesting result that participants with high air pollutant exposures and low genetic risk scores had the highest risk of developing osteoporosis—an 86.1% greater risk than participants with low air pollutant exposure and a high genetic risk score.18 Of note, while family history of hip fracture or osteoporosis may increase an individual’s own osteoporosis or fracture risk,19,20 studies continue to clarify how much the risk increases among different populations and the polygenic factors involved.5

Another interesting 2022 study (n=529 women; median age 76 years; Beijing residents) investigated the relationship between traffic-related air pollution exposure and the incidence of osteoporotic fractures.21 In the study, distances were designated in units representing the closest, medium, and farthest proximities. After adjusting for confounders, analysis indicated that compared to the farthest distance, those living closest to a major roadway had a 159% higher risk of osteoporotic fracture incidence while those living within a medium distance had an 87% higher risk.21

Clinical Applications: Reducing Exposures & Lifestyle-Based Approaches

Avoiding or reducing pollutant and hazardous chemical exposures is an important component for bone health as well as for overall health and wellness. Awareness of potential chronic exposures and the level of exposure are important factors to discuss with patients as they may indicate the extent of impact and inform any treatment considerations.

As part of a patient’s personalized bone health and treatment plan, specific strategies to reduce chronic toxicant exposures may include avoiding direct and indirect exposure to cigarette smoke, avoiding plastic food and beverage packaging, using HEPA air purifiers, removing outdoor shoes upon entry to the home, and choosing organic versions of high-pesticide produce. As part of IFM’s extensive toolkit, available to IFM members, Reducing Exposures to Harmful Chemicals is a clinical tool that provides a range of valuable suggestions and approaches for clinicians and their patients.

In addition to reducing exposures to environmental toxicants, other lifestyle-based approaches may be implemented to support skeletal health. Research studies suggest that anti-inflammatory, Mediterranean-style diets,22,23 physical activity and resistance-based exercise,24 and specific vitamins and minerals, supplements, and nutraceuticals such as calcium, vitamin D, vitamin K,25 isoflavones (abundant in soybeans and other legumes),26,27 omega-3 fatty acids,28 and probiotics26,29 may positively impact bone density and quality.

Understanding how environmental toxicants impact body tissues and taking practical steps to improve biotransformation and detoxification pathways may help to improve a patient’s overall health and well-being. Learn more about those clinical tools and personalized approaches that help ensure health at IFM’s Environmental Health Advanced Practice Module (APM).

New call-to-action
REFERENCES
  1. Wang S, Greenbaum J, Qiu C, et al. Single-cell RNA sequencing reveals in vivo osteoimmunology interactions between the immune and skeletal systems. Front Endocrinol (Lausanne). 2023;14:1107511. doi:10.3389/fendo.2023.1107511
  2. Emmanuelle NE, Marie-Cécile V, Florence T, et al. Critical role of estrogens on bone homeostasis in both male and female: from physiology to medical implications. Int J Mol Sci. 2021;22(4):1568. doi:10.3390/ijms22041568
  3. Bassett JH, Williams GR. Role of thyroid hormones in skeletal development and bone maintenance. Endocr Rev. 2016;37(2):135-187. doi:10.1210/er.2015-1106
  4. Bhardwaj A, Sapra L, Tiwari A, Mishra PK, Sharma S, Srivastava RK. "Osteomicrobiology": the nexus between bone and bugs. Front Microbiol. 2022;12:812466. doi:10.3389/fmicb.2021.812466
  5. Kim SK. Identification of 613 new loci associated with heel bone mineral density and a polygenic risk score for bone mineral density, osteoporosis and fracture [published correction appears in PLoS One. 2019;14(3):e0213962]. PLoS One. 2018;13(7):e0200785. doi:10.1371/journal.pone.0200785
  6. Pizzorno J, Pizzorno L. Environmental toxins are a major cause of bone loss. Integr Med (Encinitas). 2021;20(1):10-17.
  7. Jalili C, Kazemi M, Taheri E, et al. Exposure to heavy metals and the risk of osteopenia or osteoporosis: a systematic review and meta-analysis. Osteoporos Int. 2020;31(9):1671-1682. doi:10.1007/s00198-020-05429-6
  8. Reeves KW, Vieyra G, Grimes NP, et al. Urinary phthalate biomarkers and bone mineral density in postmenopausal women. J Clin Endocrinol Metab. 2021;106(7):e2567-e2579. doi:10.1210/clinem/dgab189
  9. Wang N, Wang Y, Zhang H, et al. Association of bone mineral density with nine urinary personal care and consumer product chemicals and metabolites: a national-representative, population-based study. Environ Int. 2020;142:105865. doi:10.1016/j.envint.2020.105865
  10. Huang Z, Wang X, Wang H, Zhang S, Du X, Wei H. Relationship of blood heavy metals and osteoporosis among the middle-aged and elderly adults: a secondary analysis from NHANES 2013 to 2014 and 2017 to 2018. Front Public Health. 2023;11:1045020. doi:10.3389/fpubh.2023.1045020
  11. Kunioka CT, Manso MC, Carvalho M. Association between environmental cadmium exposure and osteoporosis risk in postmenopausal women: a systematic review and meta-analysis. Int J Environ Res Public Health. 2022;20(1):485. doi:10.3390/ijerph20010485
  12. Xie R, Liu Y, Wang J, et al. Race and gender differences in the associations between cadmium exposure and bone mineral density in US adults. Biol Trace Elem Res. 2023;201(9):4254-4261. doi:10.1007/s12011-022-03521-y
  13. García-Recio E, Costela-Ruiz VJ, Melguizo-Rodríguez L, et al. Effects of bisphenol F, bisphenol S, and bisphenol AF on cultured human osteoblasts. Arch Toxicol. 2023;97(7):1899-1905. doi:10.1007/s00204-023-03523-2
  14. Di D, Zhang R, Zhou H, et al. Joint effects of phenol, chlorophenol pesticide, phthalate, and polycyclic aromatic hydrocarbon on bone mineral density: comparison of four statistical models. Environ Sci Pollut Res Int. 2023;30(33):80001-80013. doi:10.1007/s11356-023-28065-z
  15. Prada D, Zhong J, Colicino E, et al. Association of air particulate pollution with bone loss over time and bone fracture risk: analysis of data from two independent studies. Lancet Planet Health. 2017;1(8):e337-e347. doi:10.1016/S2542-5196(17)30136-5
  16. Yang Y, Li R, Cai M, et al. Ambient air pollution, bone mineral density and osteoporosis: results from a national population-based cohort study. Chemosphere. 2023;310:136871. doi:10.1016/j.chemosphere.2022.136871
  17. Xu C, Weng Z, Liu Q, et al. Association of air pollutants and osteoporosis risk: the modifying effect of genetic predisposition. Environ Int. 2022;170:107562. doi:10.1016/j.envint.2022.107562
  18. Yu XH, Cao HW, Bo L, Lei SF, Deng FY. Air pollution, genetic factors and the risk of osteoporosis: a prospective study in the UK biobank. Front Public Health. 2023;11:1119774. doi:10.3389/fpubh.2023.1119774
  19. Mitek T, Nagraba Ł, Deszczyński J, Stolarczyk M, Kuchar E, Stolarczyk A. Genetic predisposition for osteoporosis and fractures in postmenopausal women. Adv Exp Med Biol. 2019;1211:17-24. doi:10.1007/5584_2019_413
  20. National Institute of Arthritis and Musculoskeletal and Skin Diseases. Osteoporosis. National Institutes of Health. Reviewed December 2022. Accessed October 17, 2023. https://www.niams.nih.gov/health-topics/osteoporosis
  21. Ren Y, Li W, Chen Z, Liu J, Fan D. Proximity to major roads and the incidence of osteoporotic fractures in elderly women: the BONE study in Beijing. Front Public Health. 2022;10:1036534. doi:10.3389/fpubh.2022.1036534
  22. Malmir H, Saneei P, Larijani B, Esmaillzadeh A. Adherence to Mediterranean diet in relation to bone mineral density and risk of fracture: a systematic review and meta-analysis of observational studies. Eur J Nutr. 2018;57(6):2147-2160. doi:10.1007/s00394-017-1490-3 
  23. Boushey C, Ard J, Bazzano L, et al. Dietary Patterns and Bone Health: A Systematic Review. USDA Nutrition Evidence Systematic Review; July 2020. doi:10.52570/NESR.DGAC2020.SR0105
  24. Pinheiro MB, Oliveira J, Bauman A, Fairhall N, Kwok W, Sherrington C. Evidence on physical activity and osteoporosis prevention for people aged 65+ years: a systematic review to inform the WHO guidelines on physical activity and sedentary behaviour. Int J Behav Nutr Phys Act. 2020;17(1):150. doi:10.1186/s12966-020-01040-4
  25. Bone Health and Osteoporosis Foundation. Nutrients: bone healthy ingredients. Accessed October 12, 2023. https://www.bonehealthandosteoporosis.org/preventing-fractures/nutrition-for-bone-health/nutrients/
  26. Lambert MNT, Thybo CB, Lykkeboe S, et al. Combined bioavailable isoflavones and probiotics improve bone status and estrogen metabolism in postmenopausal osteopenic women: a randomized controlled trial. Am J Clin Nutr. 2017;106(3):909-920. doi:10.3945/ajcn.117.153353
  27. Chen LR, Ko NY, Chen KH. Isoflavone supplements for menopausal women: a systematic review. Nutrients. 2019;11(11):2649. doi:10.3390/nu11112649
  28. Shen D, Zhang X, Li Z, Bai H, Chen L. Effects of omega-3 fatty acids on bone turnover markers in postmenopausal women: systematic review and meta-analysis. Climacteric. 2017;20(6):522-527. doi:10.1080/13697137.2017.1384952
  29. Nilsson AG, Sundh D, Backhed F, Lorentzon M. Lactobacillus reuteri reduces bone loss in older women with low bone mineral density: a randomized, placebo-controlled, double-blind, clinical trial. J Intern Med. 2018;284(3):307-317. doi:10.1111/joim.12805